BAT Releases glo HYPER PRO in Bosnia and Herzegovina

BAT by 2FIRSTS.ai
Jun.21.2024
BAT Releases glo HYPER PRO in Bosnia and Herzegovina
British American Tobacco (BAT) launched its latest heated tobacco device, glo HYPER PRO, in Bosnia and Herzegovina on June 20th.

According to a report by Bljesak.Info on June 20th, British American Tobacco (BAT) unveiled its latest heated tobacco device, glo HYPER PRO, for the first time in Bosnia and Herzegovina.

 

Previously, glo HYPER PRO had been launched in Croatia, Serbia, Italy, Poland, Japan, and other countries. With the launch of glo HYPER PRO, BAT became the first tobacco company to offer all categories of smokeless products (including e-cigarettes, nicotine pouches, and the current glo HYPER PRO heated tobacco product) in the Bosnian market. The company claims that these are also important steps towards BAT's commitment to creating "A Better Tomorrow™" and realizing its vision of a smoke-free world. The company's strategic goal is to shift smokers from traditional tobacco products to lower-risk alternative products, with the aim of becoming the leading company in the smokeless industry by 2035.

 

Furthermore, BAT emphasized its significant contribution to the economy of Bosnia and Herzegovina. BAT has operations in the country, including corporate offices and iNovina, as well as over 400 iNovina kiosks nationwide. In addition, they directly employ over 1000 people in Bosnia and Herzegovina, providing more job opportunities for locals. In 2023, they contributed 336 million convertible marks (KM) to the national budget of Bosnia and Herzegovina.

 

BAT Bosnia and Herzegovina director Johan Baguca stated that

 

The glo HYPER PRO is not just a device, but a perfect combination of technological innovation and exquisite design. Its aim is to introduce new technologies, such as smart LED screens and the HeatBoost induction heating system... For us, the most important thing is the satisfaction of nearly nine million adult glo users worldwide. We believe that this device will be well-received in Bosnia and Herzegovina and will certainly further enhance our position as the only company in the industry to offer a full range of low-risk smoke-free products in the country.

 

The General Manager of BAT Adriatic Region, Zvonko Kolobara, stated

 

I am proud of the launch of our glo HYPER PRO device, which has fully encompassed the low risk product category in the entire Adriatic region market, including Bosnia and Herzegovina, within our BAT product line. This is crucial for BAT and our future business. The key is that we need to offer as wide a range as possible of lower risk alternative products for our consumers, adult smokers. Over the past three years, BAT has invested over 1.4 billion euros in research and development, commercialization, and scientific studies to support its portfolio of lower risk tobacco and nicotine products. These efforts are crucial, as clear regulatory frameworks are needed to differentiate between tobacco and lower risk products and understand the potential of these alternatives for adult smokers.

 

Currently, the glo HYPER PRO device is now available for purchase at iNovina newsstands and other retail locations in Bosnia and Herzegovina.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
According to Investing.com citing Bank of America scanner data for the four weeks ending May 30, U.S. nicotine category performance was mixed, with cigarette, vapor and cigar sales declining while oral tobacco sales rose 5.8%.
Jun.10
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey, daily smoking among Australians aged 18 and over fell to a record low of 5.8% in 2025. Health Minister Mark Butler said Australia now has around 500,000 fewer daily smokers than three years ago and credited the government’s vaping reforms as part of broader progress. Among people aged 14 and over, daily smoking declined from 8.3% in 2022-23 to 5.6% in 2025. Daily vaping rates stabilised at 3.6%, while the government also moved to further restrict access to nicotine pouches through unapproved therapeutic import pathways.
Jul.21
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
A former FDA toxicologist has questioned whether the agency fully assessed the material used in ZYN nicotine pouches before authorizing them for sale, raising concerns over possible microplastic exposure, according to STAT and The Examination.
Jul.16
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25
2Firsts Interview | InterTabac 2026 Adapts to a More Complex Tobacco and Nicotine Market
2Firsts Interview | InterTabac 2026 Adapts to a More Complex Tobacco and Nicotine Market
As InterTabac 2026 approaches, Sabine Loos, Managing Director of Westfalenhallen Unternehmensgruppe, tells 2Firsts that global tobacco trade fairs are evolving beyond product display. With new nicotine categories, shifting regulation and more complex supply chains reshaping the industry, InterTabac is positioning itself as a platform for market insight, regulatory discussion and global business connection.
Special Report
Jul.02
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12